ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 91 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2018. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $425,246 | +71.6% | 137,620 | +43.3% | 0.00% | – |
Q1 2024 | $247,783 | +3.2% | 96,040 | 0.0% | 0.00% | – |
Q4 2023 | $240,100 | +29.8% | 96,040 | +5.4% | 0.00% | – |
Q3 2023 | $184,933 | -4.5% | 91,100 | +8.2% | 0.00% | – |
Q2 2023 | $193,591 | +11.5% | 84,170 | +46.9% | 0.00% | – |
Q1 2023 | $173,619 | +51.8% | 57,300 | +16.7% | 0.00% | – |
Q4 2022 | $114,403 | +87.5% | 49,100 | +54.4% | 0.00% | – |
Q3 2022 | $61,000 | -7.6% | 31,800 | +31.4% | 0.00% | – |
Q2 2022 | $66,000 | +57.1% | 24,200 | +71.6% | 0.00% | – |
Q1 2022 | $42,000 | -23.6% | 14,100 | 0.0% | 0.00% | – |
Q4 2021 | $55,000 | -8.3% | 14,100 | 0.0% | 0.00% | – |
Q3 2021 | $60,000 | +39.5% | 14,100 | 0.0% | 0.00% | – |
Q2 2021 | $43,000 | -84.8% | 14,100 | -52.7% | 0.00% | – |
Q3 2018 | $282,000 | – | 29,821 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Two Seas Capital LP | 7,504,193 | $17,484,770 | 16.61% |
Whitefort Capital Management, LP | 3,850,769 | $8,972,292 | 6.97% |
FourWorld Capital Management LLC | 2,000,090 | $4,660,210 | 6.41% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 187,400 | $436,642 | 0.53% |
Oasis Management Co Ltd. | 1,088,895 | $2,537,125 | 0.50% |
Rubric Capital Management LP | 3,466,281 | $8,076,435 | 0.35% |
Tejara Capital Ltd | 200,000 | $466,000 | 0.27% |
Hudson Bay Capital Management LP | 4,851,416 | $11,303,799 | 0.12% |
ETF MANAGERS GROUP, LLC | 639,973 | $1,491,137 | 0.07% |
Kepos Capital LP | 200,000 | $466 | 0.07% |